Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2012

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the transition period from              to             

Commission File Number 1-12981

 

 

AMETEK, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   14-1682544

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

1100 Cassatt Road

P.O. Box 1764

Berwyn, Pennsylvania

  19312-1177
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (610) 647-2121

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer x

  Accelerated filer ¨  

Non-accelerated filer ¨

(Do not check if a smaller reporting company)

  Smaller reporting company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares of the registrant’s common stock outstanding as of the latest practicable date was: Common Stock, $0.01 Par Value, outstanding at October 25, 2012 was 242,984,286 shares.

 

 

 


Table of Contents

AMETEK, Inc.

Form 10-Q

Table of Contents

 

          Page  

PART I. FINANCIAL INFORMATION

  
  

Item 1. Financial Statements

  
  

Consolidated Statement of Income for the three and nine months ended September 30, 2012 and 2011

     2   
  

Consolidated Statement of Comprehensive Income for the three and nine months ended September  30, 2012 and 2011

     3   
  

Consolidated Balance Sheet at September 30, 2012 and December 31, 2011

     4   
  

Condensed Consolidated Statement of Cash Flows for the nine months ended September 30, 2012 and 2011

     5   
  

Notes to Consolidated Financial Statements

     6   
  

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     15   
  

Item 4. Controls and Procedures

     21   

PART II. OTHER INFORMATION

  
  

Item 6. Exhibits

     22   

SIGNATURES

     23   

 

1


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

AMETEK, Inc.

Consolidated Statement of Income

(In thousands, except per share amounts)

(Unaudited)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2012     2011     2012     2011  

Net sales

   $ 839,373      $ 750,546      $ 2,492,423      $ 2,227,163   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

        

Cost of sales, excluding depreciation

     541,454        493,266        1,609,490        1,466,026   

Selling, general and administrative

     96,021        86,019        286,703        257,196   

Depreciation

     13,734        11,675        40,312        35,380   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     651,209        590,960        1,936,505        1,758,602   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     188,164        159,586        555,918        468,561   

Other expenses:

        

Interest expense

     (18,958     (17,256     (56,638     (51,745

Other, net

     (3,518     (3,287     (7,606     (7,153
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     165,688        139,043        491,674        409,663   

Provision for income taxes

     50,291        41,065        152,440        127,106   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 115,397      $ 97,978      $ 339,234      $ 282,557   
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic earnings per share

   $ 0.48      $ 0.41      $ 1.41      $ 1.17   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted earnings per share

   $ 0.47      $ 0.40      $ 1.39      $ 1.16   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average common shares outstanding:

        

Basic shares

     242,138        241,386        241,164        240,529   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted shares

     244,229        243,771        243,552        243,457   
  

 

 

   

 

 

   

 

 

   

 

 

 

Dividends declared and paid per share

   $ 0.06      $ 0.04      $ 0.16      $ 0.12   
  

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes.

 

2


Table of Contents

AMETEK, Inc.

Consolidated Statement of Comprehensive Income

(In thousands)

(Unaudited)

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2012      2011      2012      2011  

Comprehensive income

   $ 135,062       $ 62,610       $ 355,212       $ 272,604   
  

 

 

    

 

 

    

 

 

    

 

 

 

See accompanying notes.

 

3


Table of Contents

AMETEK, Inc.

Consolidated Balance Sheet

(In thousands)

 

     September 30,
2012
    December 31,
2011
 
     (Unaudited)        

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 162,851      $ 170,392   

Marketable securities

     5,253        4,563   

Receivables, less allowance for possible losses

     492,864        438,245   

Inventories

     407,898        380,471   

Deferred income taxes

     30,825        29,268   

Other current assets

     36,141        36,180   
  

 

 

   

 

 

 

Total current assets

     1,135,832        1,059,119   

Property, plant and equipment, net

     361,680        325,329   

Goodwill

     2,065,772        1,806,237   

Other intangibles, net of accumulated amortization

     1,188,153        982,957   

Investments and other assets

     142,074        145,848   
  

 

 

   

 

 

 

Total assets

   $ 4,893,511      $ 4,319,490   
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Short-term borrowings and current portion of long-term debt

   $ 242,781      $ 140,508   

Accounts payable

     288,221        283,068   

Income taxes payable

     34,717        24,127   

Accrued liabilities

     196,674        181,172   
  

 

 

   

 

 

 

Total current liabilities

     762,393        628,875   

Long-term debt

     1,129,383        1,123,416   

Deferred income taxes

     432,797        389,088   

Other long-term liabilities

     145,070        125,306   
  

 

 

   

 

 

 

Total liabilities

     2,469,643        2,266,685   
  

 

 

   

 

 

 

Stockholders’ equity:

    

Common stock, $0.01 par value; authorized: 400,000,000 shares; issued: 255,984,466 and 253,824,112 shares

     2,561        2,538   

Capital in excess of par value

     376,352        315,688   

Retained earnings

     2,402,092        2,101,615   

Accumulated other comprehensive loss

     (141,285     (157,263

Treasury stock: 13,037,058 and 13,266,742 shares

     (215,852     (209,773
  

 

 

   

 

 

 

Total stockholders’ equity

     2,423,868        2,052,805   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 4,893,511      $ 4,319,490   
  

 

 

   

 

 

 

See accompanying notes.

 

4


Table of Contents

AMETEK, Inc.

Condensed Consolidated Statement of Cash Flows

(In thousands)

(Unaudited)

 

     Nine Months Ended
September 30,
 
     2012     2011  

Cash provided by (used for):

    

Operating activities:

    

Net income

   $ 339,234      $ 282,557   

Adjustments to reconcile net income to total operating activities:

    

Depreciation and amortization

     77,845        62,527   

Deferred income taxes

     (1,414     (134

Share-based compensation expense

     14,575        18,356   

Net change in assets and liabilities, net of acquisitions

     (8,242     (5,593

Pension contribution and other

     (2,824     (1,874
  

 

 

   

 

 

 

Total operating activities

     419,174        355,839   
  

 

 

   

 

 

 

Investing activities:

    

Additions to property, plant and equipment

     (33,256     (32,410

Purchases of businesses, net of cash acquired

     (497,785     (182,506

Other

     649        (2,150
  

 

 

   

 

 

 

Total investing activities

     (530,392     (217,066
  

 

 

   

 

 

 

Financing activities:

    

Net change in short-term borrowings

     101,818        (56,517

Reduction in long-term borrowings

     (978     (781

Repurchases of common stock

     (3,899     (16,384

Cash dividends paid

     (38,556     (28,800

Excess tax benefits from share-based payments

     12,319        11,654   

Proceeds from employee stock plans and other

     30,739        12,615   
  

 

 

   

 

 

 

Total financing activities

     101,443        (78,213
  

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     2,234        (5,494
  

 

 

   

 

 

 

(Decrease) increase in cash and cash equivalents

     (7,541     55,066   

Cash and cash equivalents:

    

As of January 1

     170,392        163,208   
  

 

 

   

 

 

 

As of September 30

   $ 162,851      $ 218,274   
  

 

 

   

 

 

 

See accompanying notes.

 

5


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2012

(Unaudited)

 

1. Basis of Presentation

The accompanying consolidated financial statements are unaudited. AMETEK, Inc. (the “Company”) believes that all adjustments (which primarily consist of normal recurring accruals) necessary for a fair presentation of the consolidated financial position of the Company at September 30, 2012, the consolidated results of its operations for the three and nine months ended September 30, 2012 and 2011 and its cash flows for the nine months ended September 30, 2012 and 2011 have been included. Quarterly results of operations are not necessarily indicative of results for the full year. The accompanying financial statements should be read in conjunction with the financial statements and related notes presented in the Company’s Annual Report on Form

10-K for the year ended December 31, 2011 as filed with the Securities and Exchange Commission.

 

2. Stock Split

On May 1, 2012, the Company’s Board of Directors declared a three-for-two split of the Company’s common stock. The stock split resulted in the issuance of one additional share for every two shares owned. The stock split was paid on June 29, 2012, to stockholders of record at the close of business on June 15, 2012. Additionally, the Board of Directors approved a 50% increase in the quarterly cash dividend rate on the Company’s common stock to $0.06 per common share from $0.04 per common share on a post-split basis. All share and per share information included in this Quarterly Report on Form 10-Q has been retroactively adjusted to reflect the impact of the stock split.

 

3. Recent Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs (“ASU 2011-04”). ASU 2011-04 amendments result in a consistent definition of fair value and common requirements for measurement of and disclosure about fair value between U.S. generally accepted accounting principles (“GAAP”) and International Financial Reporting Standards (“IFRSs”). ASU 2011-04 was effective on January 1, 2012 for the Company and the adoption did not have a significant impact on the Company’s consolidated results of operations, financial position or cash flows.

In June 2011, the FASB issued ASU No. 2011-05, Presentation of Comprehensive Income (“ASU 2011-05”). ASU 2011-05 requires that all nonowner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In the two-statement approach, the first statement should present total net income and its components followed consecutively by a second statement that should present total other comprehensive income, the components of other comprehensive income and the total of comprehensive income. For interim periods, issuers are only required to provide a total of comprehensive income. These amendments do not change the items that must be reported in other comprehensive income. The Company adopted ASU 2011-05 effective January 1, 2012. See the Consolidated Statement of Comprehensive Income.

In September 2011, the FASB issued ASU No. 2011-08, Testing Goodwill for Impairment (“ASU 2011-08”). The amendments in ASU 2011-08 permit an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test described in FASB Accounting Standards Codification Topic 350, Intangibles – Goodwill and Other. ASU 2011-08 was effective on January 1, 2012 for the Company and the adoption did not have a significant impact on the Company’s consolidated results of operations, financial position or cash flows.

In July 2012, the FASB issued ASU No. 2012-02, Testing Indefinite-Lived Intangible Assets for Impairment (“ASU 2012-02”). The amendments in ASU 2012-02, similar to the amendments of ASU 2011-08, permit an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is impaired, as a basis for determining whether it is necessary to perform the quantitative impairment test described in FASB Accounting Standards Codification Topic 350, Intangibles – Goodwill and Other. ASU 2012-02 is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The Company does not expect ASU 2012-02 to have a significant impact on the Company’s consolidated results of operations, financial position or cash flows.

 

6


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2012

(Unaudited)

 

4. Earnings Per Share

The calculation of basic earnings per share is based on the weighted average number of common shares considered outstanding during the periods. The calculation of diluted earnings per share reflects the effect of all potentially dilutive securities (principally outstanding stock options and restricted stock grants). The number of weighted average shares used in the calculation of basic earnings per share and diluted earnings per share was as follows:

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2012      2011      2012      2011  
     (In thousands)  

Weighted average shares:

           

Basic shares

     242,138         241,386         241,164         240,529   

Equity-based compensation plans

     2,091         2,385         2,388         2,928   
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted shares

     244,229         243,771         243,552         243,457   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

5. Comprehensive Income

The difference between net income and comprehensive income in the periods presented is primarily driven by foreign currency translation adjustments, as well as the net gains or losses on net investment hedges of certain foreign subsidiaries, amortization of defined benefit pension actuarial gains or losses and other.

 

6. Fair Value Measurements

Cash, cash equivalents, marketable securities and fixed-income investments are recorded at fair value at September 30, 2012 and December 31, 2011 in the accompanying consolidated balance sheet.

The Company utilizes a valuation hierarchy for disclosure of the inputs to the valuations used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

At September 30, 2012, the Company held $5.3 million in marketable securities, of which $5.1 million was held in an institutional diversified equity securities mutual fund, which is valued as a level 2 investment. In addition, the Company held $0.2 million of marketable securities valued as level 1 investments. The marketable securities are shown as a separate line on the consolidated balance sheet. Fair value of the institutional diversified equity securities mutual fund was estimated using the net asset value of the Company’s ownership interests in the fund’s capital. The mutual fund seeks to provide long-term growth of capital by investing primarily in equity securities traded on U.S. exchanges and issued by large, established companies across many business sectors. There are no restrictions on the Company’s ability to redeem these equity securities investments.

At September 30, 2012, the Company held $3.0 million in fixed-income investments. The fair value of fixed-income investments was based on quoted market prices which are valued as level 1 investments. The fixed-income investments are shown as a component of long-term assets on the consolidated balance sheet.

For the nine months ended September 30, 2012, gains and losses on the investments noted above were not significant. No transfers between level 1 and level 2 investments occurred during the nine months ended September 30, 2012.

 

7


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2012

(Unaudited)

 

Forward contracts are entered into from time to time to hedge specific firm commitments for certain inventory purchases, export sales or debt, thereby minimizing the Company’s exposure to raw material commodity price or foreign currency fluctuation. At September 30, 2012, the Company had a 9.9 million Euro forward contract ($27 thousand fair value unrealized loss at September 30, 2012) outstanding. For the three months ended September 30, 2012, realized gains on foreign currency forward contracts was $0.3 million. For the nine months ended September 30, 2012, realized losses on foreign currency forward contracts was $2.4 million. For the three and nine months ended September 30, 2012, unrealized gains or losses on the forward contracts were not significant. The Company has not designated its foreign currency forward contracts as hedges. No forward contracts were outstanding at December 31, 2011.

 

7. Hedging Activities

The Company has designated certain foreign-currency-denominated long-term borrowings as hedges of the net investment in certain foreign operations. As of September 30, 2012, these net investment hedges included British-pound- and Euro-denominated long-term debt. These borrowings were designed to create net investment hedges in each of the designated foreign subsidiaries. The Company designated the British-pound- and Euro-denominated loans referred to above as hedging instruments to offset translation gains or losses on the net investment due to changes in the British pound and Euro exchange rates. These net investment hedges were evidenced by management’s contemporaneous documentation supporting the hedge designation. Any gain or loss on the hedging instrument (the debt) following hedge designation is reported in accumulated other comprehensive income in the same manner as the translation adjustment on the investment based on changes in the spot rate, which is used to measure hedge effectiveness.

At September 30, 2012, the Company had $194.0 million of British-pound-denominated loans, which are designated as a hedge against the net investment in British pound functional currency foreign subsidiaries. At September 30, 2012, the Company had a $64.3 million Euro-denominated loan, which is designated as a hedge against the net investment in Euro functional currency foreign subsidiaries. As a result of these British-pound- and Euro-denominated loans being designated and 100% effective as net investment hedges, $5.6 million of currency remeasurement losses have been included in the foreign currency translation component of other comprehensive income at September 30, 2012.

 

8. Inventories

 

     September 30,
2012
     December 31,
2011
 
     (In thousands)  

Finished goods and parts

   $ 66,642       $ 70,315   

Work in process

     73,206         72,676   

Raw materials and purchased parts

     268,050         237,480   
  

 

 

    

 

 

 

Total inventories

   $ 407,898       $ 380,471   
  

 

 

    

 

 

 

 

8


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2012

(Unaudited)

 

9. Acquisitions

The Company spent $497.8 million in cash, net of cash acquired, to acquire O’Brien Corporation in January 2012 and the parent company of Dunkermotoren GmbH in May 2012. O’Brien is a leading manufacturer of fluid and gas handling solutions, sample conditioning equipment and process analyzers. Dunkermotoren is a leader in advanced motion control solutions for a wide range of industrial automation applications. O’Brien is part of AMETEK’s Electronic Instruments Group and Dunkermotoren is part of AMETEK’s Electromechanical Group.

The operating results of the above acquisitions have been included in the Company’s consolidated results from the respective dates of acquisitions.

The following table represents the preliminary allocation of the aggregate purchase price for the net assets of the above acquisitions based on the estimated fair value at acquisition (in millions):

 

Property, plant and equipment

   $ 43.6   

Goodwill

     251.8   

Other intangible assets

     238.5   

Deferred income taxes

     (46.8

Net working capital and other*

     10.7   
  

 

 

 

Total purchase price

   $ 497.8   
  

 

 

 

 

* Includes $31.4 million in accounts receivable, whose fair value, contractual cash flows and expected cash flows are approximately equal.

The amount allocated to goodwill is reflective of the benefits the Company expects to realize from the acquisitions as follows: O’Brien’s product lines are both highly differentiated and highly complementary to AMETEK’s process instruments businesses. Combined with the Company’s analytical instrument solutions, AMETEK now can offer its customers a complete solution for most of their process analysis needs. Dunkermotoren is a strategic and highly complementary fit with AMETEK’s Precision Motion Control business. Dunkermotoren expands the Company’s leadership position in niche rotary and linear motion applications. The Company expects approximately $112.4 million of the goodwill recorded in connection with the 2012 acquisitions will be tax deductible in future years.

The Company is in the process of finalizing the measurement of deferred taxes associated with its acquisitions of O’Brien and Dunkermotoren.

At September 30, 2012, purchase price allocated to other intangible assets of $238.5 million consists of $65.6 million of indefinite-lived intangible trademarks and trade names, which are not subject to amortization. The remaining $172.9 million of other intangible assets consist of $148.7 million of customer relationships, which are being amortized over a period of 16-20 years and $24.2 million of purchased technology, which is being amortized over a period of 15 years. Amortization expense for each of the next five years for the 2012 acquisitions listed above is expected to approximate $9.5 million per year.

The 2012 acquisitions noted above had an immaterial impact on reported net sales, net income and diluted earnings per share for the three and nine months ended September 30, 2012. Had the 2012 acquisitions been made at the beginning of 2012, unaudited pro forma net sales, net income and diluted earnings per share for the three and nine months ended September 30, 2012 would not have been materially different than the amounts reported. Had the 2012 acquisitions been made at the beginning of 2011, unaudited pro forma net sales for the three and nine months ended September 30, 2011 would have been $825.6 million and $2,447.1 million, respectively. Net income and diluted earnings per share for the three and nine months ended September 30, 2011 would not have been materially different than the amounts reported. Pro forma results are not necessarily indicative of the results that would have occurred if the acquisition had been completed at the beginning of 2012 or 2011.

 

9


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2012

(Unaudited)

 

Acquisitions Subsequent to September 30, 2012

In October 2012, the Company acquired Micro-Poise Measurement Systems (“Micro-Poise”), a leading provider of integrated test and measurement solutions for the tire industry. Micro-Poise was acquired for approximately $170 million and has estimated annual sales of approximately $125 million. Micro-Poise broadens AMETEK’s position in the materials test and measurement equipment market and will join AMETEK’s Electronic Instruments Group.

 

10. Goodwill

The changes in the carrying amounts of goodwill by segment were as follows:

 

     Electronic
Instruments
Group
    Electro-
mechanical
Group
     Total  
     (In millions)  

Balance at December 31, 2011

   $ 997.7      $ 808.5       $ 1,806.2   

Goodwill acquired

     111.3        140.5         251.8   

Purchase price allocation adjustments and other

     (0.6     —           (0.6

Foreign currency translation adjustments

     3.9        4.5         8.4   
  

 

 

   

 

 

    

 

 

 

Balance at September 30, 2012

   $ 1,112.3      $ 953.5       $ 2,065.8   
  

 

 

   

 

 

    

 

 

 

 

11. Income Taxes

At September 30, 2012, the Company had gross unrecognized tax benefits of $33.5 million, of which $30.9 million, if recognized, would impact the effective tax rate.

The following is a reconciliation of the liability for uncertain tax positions (in millions):

 

Balance at December 31, 2011

   $ 28.5   

Additions for tax positions

     5.5   

Reductions for tax positions

     (0.5
  

 

 

 

Balance at September 30, 2012

   $ 33.5   
  

 

 

 

The Company recognizes interest and penalties accrued related to uncertain tax positions in income tax expense. The amounts recognized in income tax expense for interest and penalties during the three and nine months ended September 30, 2012 and 2011 were not significant.

 

12. Financial Instruments

The estimated fair values of the Company’s financial instruments, for which fair value is measured for disclosure purposes only, are compared below to the recorded amounts at September 30, 2012 and December 31, 2011.

 

     Asset (Liability)  
     September 30, 2012     December 31, 2011  
     Recorded
Amount
    Fair Value     Recorded
Amount
    Fair Value  
     (In thousands)  

Short-term borrowings

   $ (235,433   $ (235,433   $ (135,892   $ (135,892

Long-term debt (including current portion)

     (1,136,731     (1,362,598     (1,128,032     (1,298,503

The fair value of short-term borrowings approximates the carrying value. The Company’s long-term debt is all privately held with no public market for this debt, therefore, the fair value of long-term debt was computed based on comparable current market data for similar debt instruments.

 

10


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2012

(Unaudited)

 

13. Share-Based Compensation

The fair value of each stock option grant is estimated on the date of grant using a Black-Scholes-Merton option pricing model. The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of options granted during the periods indicated:

 

    Nine Months Ended
September 30, 2012
    Year Ended
December 31, 2011
 

Expected volatility

    28.4     26.4

Expected term (years)

    5.1        5.0   

Risk-free interest rate

    0.84     1.96

Expected dividend yield

    0.47     0.54

Black-Scholes-Merton fair value per stock option granted

  $ 8.54      $ 7.56   

Expected volatility is based on the historical volatility of the Company’s stock. The Company used historical exercise data to estimate the stock options’ expected term, which represents the period of time that the stock options granted are expected to be outstanding. Management anticipates that the future stock option holding periods will be similar to the historical stock option holding periods. The risk-free interest rate for periods within the contractual life of the stock option is based on the U.S. Treasury yield curve at the time of grant. Compensation expense recognized for all share-based awards is net of estimated forfeitures. The Company’s estimated forfeiture rates are based on its historical experience.

Total share-based compensation expense was as follows:

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2012     2011     2012     2011  
     (In thousands)  

Stock option expense

   $ 2,256      $ 2,095      $ 7,248      $ 6,160   

Restricted stock expense

     2,106        1,986        7,327        12,196   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total pre-tax expense

     4,362        4,081        14,575        18,356   

Related tax benefit

     (1,399     (1,333     (4,957     (5,872
  

 

 

   

 

 

   

 

 

   

 

 

 

Reduction of net income

   $ 2,963      $ 2,748      $ 9,618      $ 12,484   
  

 

 

   

 

 

   

 

 

   

 

 

 

Pre-tax share-based compensation expense is included in either cost of sales, or selling, general and administrative expenses, depending on where the recipient’s cash compensation is reported.

The following is a summary of the Company’s stock option activity and related information:

 

     Shares     Weighted
Average
Exercise Price
     Weighted
Average
Remaining
Contractual Life
     Aggregate
Intrinsic  Value
 
     (In thousands)            (Years)      (In millions)  

Outstanding at December 31, 2011

     8,198      $ 18.50         

Granted

     1,386        34.01         

Exercised

     (2,160     15.63         

Forfeited

     (101     23.32         

Expired

     (2     20.21         
  

 

 

         

Outstanding at September 30, 2012

     7,321      $ 22.22         4.2       $ 96.9   
  

 

 

   

 

 

    

 

 

    

 

 

 

Exercisable at September 30, 2012

     4,036      $ 18.90         3.3       $ 66.8   
  

 

 

   

 

 

    

 

 

    

 

 

 

 

11


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2012

(Unaudited)

 

The aggregate intrinsic value of stock options exercised during the nine months ended September 30, 2012 was $37.5 million. The total fair value of stock options vested during the nine months ended September 30, 2012 was $8.9 million. As of September 30, 2012, there was approximately $16.3 million of expected future pre-tax compensation expense related to the 3.3 million nonvested stock options outstanding, which is expected to be recognized over a weighted average period of less than two years.

The following is a summary of the Company’s nonvested restricted stock activity and related information:

 

    Shares     Weighted
Average

Grant  Date
Fair Value
 
    (In thousands)        

Nonvested restricted stock outstanding at December 31, 2011

    1,414      $ 22.71   

Granted

    400        33.79   

Vested

    (465     21.80   

Forfeited

    (39     25.89   
 

 

 

   

Nonvested restricted stock outstanding at September 30, 2012

    1,310      $ 26.32   
 

 

 

   

 

 

 

The total fair value of restricted stock that vested during the nine months ended September 30, 2012 was $10.0 million. As of September 30, 2012, there was approximately $22.3 million of expected future pre-tax compensation expense related to the 1.3 million nonvested restricted shares outstanding, which is expected to be recognized over a weighted average period of approximately two years.

 

14. Retirement and Pension Plans

The components of net periodic pension benefit expense (income) were as follows:

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2012     2011     2012     2011  
     (In thousands)  

Defined benefit plans:

        

Service cost

   $ 1,568      $ 1,094      $ 4,110      $ 3,278   

Interest cost

     7,096        7,252        20,645        21,424   

Expected return on plan assets

     (10,867     (11,259     (32,242     (33,831

Amortization of net actuarial loss and other

     2,852        1,310        8,556        3,585   
  

 

 

   

 

 

   

 

 

   

 

 

 

Pension expense (income)

     649        (1,603     1,069        (5,544
  

 

 

   

 

 

   

 

 

   

 

 

 

Other plans:

        

Defined contribution plans

     4,153        3,470        13,850        10,987   

Foreign plans and other

     1,112        1,537        3,437        3,938   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total other plans

     5,265        5,007        17,287        14,925   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net pension expense

   $ 5,914      $ 3,404      $ 18,356      $ 9,381   
  

 

 

   

 

 

   

 

 

   

 

 

 

For the nine months ended September 30, 2012 and 2011, contributions to the Company’s defined benefit pension plans were not significant.

 

12


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2012

(Unaudited)

 

15. Product Warranties

The Company provides limited warranties in connection with the sale of its products. The warranty periods for products sold vary widely among the Company’s operations, but for the most part do not exceed one year. The Company calculates its warranty expense provision based on past warranty experience and adjustments are made periodically to reflect actual warranty expenses.

Changes in the accrued product warranty obligation were as follows:

 

    Nine Months Ended
September 30,
 
    2012     2011  
    (In thousands)  

Balance at the beginning of the period

  $ 22,466      $ 18,347   

Accruals for warranties issued during the period

    8,381        9,450   

Settlements made during the period

    (7,201     (7,472

Warranty accruals related to new businesses and other during the period

    3,381        674   
 

 

 

   

 

 

 

Balance at the end of the period

  $ 27,027      $ 20,999   
 

 

 

   

 

 

 

Certain settlements of warranties made during the period were for specific nonrecurring warranty obligations. Product warranty obligations are reported as current liabilities in the consolidated balance sheet.

 

16. Contingencies

Environmental Matters

Certain historic processes in the manufacture of products have resulted in environmentally hazardous waste by-products as defined by federal and state laws and regulations. At September 30, 2012, the Company is named a Potentially Responsible Party (“PRP”) at 15 non-AMETEK-owned former waste disposal or treatment sites (the “non-owned” sites). The Company is identified as a “de minimis” party in 14 of these sites based on the low volume of waste attributed to the Company relative to the amounts attributed to other named PRPs. In ten of these sites, the Company has reached a tentative agreement on the cost of the de minimis settlement to satisfy its obligation and is awaiting executed agreements. The tentatively agreed-to settlement amounts are fully reserved. In the other four sites, the Company is continuing to investigate the accuracy of the alleged volume attributed to the Company as estimated by the parties primarily responsible for remedial activity at the sites to establish an appropriate settlement amount. At the remaining site where the Company is a non-de minimis PRP, the Company is participating in the investigation and/or related required remediation as part of a PRP Group and reserves have been established sufficient to satisfy the Company’s expected obligations. The Company historically has resolved these issues within established reserve levels and reasonably expects this result will continue. In addition to these non-owned sites, the Company has an ongoing practice of providing reserves for probable remediation activities at certain of its current or previously owned manufacturing locations (the “owned” sites). For claims and proceedings against the Company with respect to other environmental matters, reserves are established once the Company has determined that a loss is probable and estimable. This estimate is refined as the Company moves through the various stages of investigation, risk assessment, feasibility study and corrective action processes. In certain instances, the Company has developed a range of estimates for such costs and has recorded a liability based on the low end of the range. It is reasonably possible that the actual cost of remediation of the individual sites could vary from the current estimates and the amounts accrued in the consolidated financial statements; however, the amounts of such variances are not expected to result in a material change to the consolidated financial statements. In estimating the Company’s liability for remediation, the Company also considers the likely proportionate share of the anticipated remediation expense and the ability of the other PRPs to fulfill their obligations.

 

13


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2012

(Unaudited)

 

Total environmental reserves at September 30, 2012 and December 31, 2011 were $23.7 million and $28.0 million, respectively, for both non-owned and owned sites. For the nine months ended September 30, 2012, the Company recorded $0.5 million in reserves. Additionally, the Company spent $4.8 million on environmental matters for the nine months ended September 30, 2012. The Company’s reserves for environmental liabilities at September 30, 2012 and December 31, 2011 include reserves of $14.8 million and $17.5 million, respectively, for an owned site acquired in connection with the 2005 acquisition of HCC Industries (“HCC”). The Company is the designated performing party for the performance of remedial activities for one of several operating units making up a large Superfund site in the San Gabriel Valley of California. The Company has obtained indemnifications and other financial assurances from the former owners of HCC related to the costs of the required remedial activities. At September 30, 2012, the Company had $13.5 million in receivables related to HCC for probable recoveries from third-party escrow funds and other committed third-party funds to support the required remediation. Also, the Company is indemnified by HCC’s former owners for approximately $19.0 million of additional costs.

The Company has agreements with other former owners of certain of its acquired businesses, as well as new owners of previously owned businesses. Under certain of the agreements, the former or new owners retained, or assumed and agreed to indemnify the Company against, certain environmental and other liabilities under certain circumstances. The Company and some of these other parties also carry insurance coverage for some environmental matters. To date, these parties have met their obligations in all material respects.

The Company believes it has established reserves which are sufficient to perform all known responsibilities under existing claims and consent orders. The Company has no reason to believe that other third parties would fail to perform their obligations in the future. In the opinion of management, based upon presently available information and past experience related to such matters, an adequate provision for probable costs has been made and the ultimate cost resulting from these actions is not expected to materially affect the consolidated results of operations, financial position or cash flows of the Company.

 

17. Reportable Segments

The Company has two reportable segments, Electronic Instruments Group (“EIG”) and Electromechanical Group (“EMG”). The Company identifies its operating segments for segment reporting purposes primarily on the basis of product type, production processes, distribution methods and management organizations.

At September 30, 2012, there were no significant changes in identifiable assets of reportable segments from the amounts disclosed at December 31, 2011, other than those described in the acquisitions footnote (Note 9), nor were there any significant changes in the basis of segmentation or in the measurement of segment operating results. Operating information relating to the Company’s reportable segments for the three and nine months ended September 30, 2012 and 2011 can be found in the table included in Part I, Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of this Quarterly Report on Form 10-Q.

 

14


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Results of Operations

The following table sets forth net sales and income by reportable segment and on a consolidated basis:

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2012     2011     2012     2011  
     (In thousands)  

Net sales(1):

        

Electronic Instruments

   $ 457,074      $ 409,516      $ 1,378,010      $ 1,205,740   

Electromechanical

     382,299        341,030        1,114,413        1,021,423   
  

 

 

   

 

 

   

 

 

   

 

 

 

Consolidated net sales

   $ 839,373      $ 750,546      $ 2,492,423      $ 2,227,163   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income and income before income taxes:

        

Segment operating income(2):

        

Electronic Instruments

   $ 121,579      $ 102,438      $ 362,255      $ 303,879   

Electromechanical

     77,324        68,363        226,961        200,445   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total segment operating income

     198,903        170,801        589,216        504,324   

Corporate administrative and other expenses

     (10,739     (11,215     (33,298     (35,763
  

 

 

   

 

 

   

 

 

   

 

 

 

Consolidated operating income

     188,164        159,586        555,918        468,561   

Interest and other expenses, net

     (22,476     (20,543     (64,244     (58,898
  

 

 

   

 

 

   

 

 

   

 

 

 

Consolidated income before income taxes

   $ 165,688      $ 139,043      $ 491,674      $ 409,663   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) After elimination of intra- and intersegment sales, which are not significant in amount.
(2) Segment operating income represents net sales less all direct costs and expenses (including certain administrative and other expenses) applicable to each segment, but does not include interest expense.

Results of operations for the third quarter of 2012 compared with the third quarter of 2011

For the quarter ended September 30, 2012, the Company established records for sales, operating income, operating income margins, net income, diluted earnings per share and operating cash flow. The Company achieved these results through our Operational Excellence initiatives, as well as contributions from the acquisitions of Dunkermotoren in May 2012, O’Brien Corporation in January 2012, Technical Manufacturing Corporation (“TMC”) in December 2011, and EM Test (Switzerland) GmbH and Reichert Technologies in October 2011. The full year impact of the 2012 and 2011 acquisitions and our Operational Excellence capabilities are expected to have a positive impact on the remainder of our 2012 results.

Net sales for the third quarter of 2012 were $839.4 million, an increase of $88.9 million or 11.8%, compared with net sales of $750.5 million for the third quarter of 2011. The net sales increase for the third quarter of 2012 was driven by the acquisitions mentioned above and internal sales growth of approximately 2%, partially offset by a 2% unfavorable effect of foreign currency translation.

Total international sales for the third quarter of 2012 were $437.8 million or 52.2% of net sales, an increase of $64.8 million or 17.4%, compared with international sales of $373.0 million or 49.7% of net sales for the third quarter of 2011. The $64.8 million increase in international sales resulted from the acquisitions mentioned above, primarily driven by Dunkermotoren, and includes the effect of foreign currency translation. Both reportable segments of the Company maintain a strong international sales presence in Europe and Asia despite weakness in the global economy.

 

15


Table of Contents

Results of Operations (continued)

 

Segment operating income for the third quarter of 2012 was $198.9 million, an increase of $28.1 million or 16.5%, compared with segment operating income of $170.8 million for the third quarter of 2011. Segment operating income, as a percentage of net sales, increased to 23.7% for the third quarter of 2012, compared with 22.8% for the third quarter of 2011. The increase in segment operating income and segment operating margins resulted primarily from the benefits of the Company’s lower cost structure through Operational Excellence initiatives.

Selling, general and administrative (“SG&A”) expenses for the third quarter of 2012 were $96.0 million, an increase of $10.0 million or 11.6%, compared with $86.0 million for the third quarter of 2011. As a percentage of net sales, SG&A expenses were 11.4% for the third quarter of 2012, essentially flat with the third quarter of 2011. Selling expense increased $10.5 million or 14.0% for the third quarter of 2012 driven by the increase in net sales noted above. Selling expense, as a percentage of net sales, increased to 10.2% for the third quarter of 2012, compared with 10.0% for the third quarter of 2011. Base business selling expense increased approximately 1% for the third quarter of 2012, which was slightly below internal sales growth.

Corporate administrative expenses for the third quarter of 2012 were $10.7 million, a decrease of $0.5 million or 4.5%, compared with $11.2 million for the third quarter of 2011. As a percentage of net sales, corporate administrative expenses were 1.3% for the third quarter of 2012, compared with 1.5% for the third quarter of 2011. The decrease in corporate administrative expenses was primarily driven by lower compensation related expenses.

Consolidated operating income was $188.2 million or 22.4% of net sales for the third quarter of 2012, an increase of $28.6 million or 17.9%, compared with $159.6 million or 21.3% of net sales for the third quarter of 2011.

Interest expense was $19.0 million for the third quarter of 2012, an increase of $1.7 million or 9.8%, compared with $17.3 million for the third quarter of 2011. The increase was primarily due to higher borrowings under revolving credit facilities for the acquisitions previously mentioned, as well as the impact of the issuance of a 55 million Swiss franc senior note in the fourth quarter of 2011.

The effective tax rate for the third quarter of 2012 was 30.4%, compared with 29.5% for the third quarter of 2011. The effective tax rate for 2012 and 2011 includes the impact of international statutory tax rate reductions and the ongoing benefits obtained from international tax planning initiatives. The third quarter of 2011 effective tax rate reflected a research and development tax credit, which was not extended into 2012. Additionally, the third quarter of 2012 had higher earnings, which mitigated the impact of the Company’s permanent differences in 2012.

Net income for the third quarter of 2012 was $115.4 million, an increase of $17.4 million or 17.8%, compared with $98.0 million for the third quarter of 2011. Diluted earnings per share for the third quarter of 2012 were $0.47, an increase of $0.07 or 17.5%, compared with $0.40 per diluted share for the third quarter of 2011. Diluted earnings per share amounts were adjusted to reflect a three-for-two stock split paid to stockholders on June 29, 2012. See Note 2 to the Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

 

16


Table of Contents

Results of Operations (continued)

 

Segment Results

Electronic Instruments Group’s (“EIG”) net sales totaled $457.1 million for the third quarter of 2012, an increase of $47.6 million or 11.6%, compared with $409.5 million for the third quarter of 2011. The net sales increase was due to internal growth of approximately 4%, excluding an unfavorable 2% effect of foreign currency translation, primarily driven by increases in EIG’s oil and gas, aerospace and power businesses. The acquisitions of O’Brien, TMC, EM Test and Reichert Technologies accounted for the remainder of the net sales increase.

EIG’s operating income was $121.6 million for the third quarter of 2012, an increase of $19.2 million or 18.8%, compared with $102.4 million for the third quarter of 2011. EIG’s operating margins were 26.6% of net sales for the third quarter of 2012, compared with 25.0% of net sales for the third quarter of 2011. The increase in segment operating income and operating margins was driven by the leveraged impact of the Group’s increase in internal sales growth noted above, as well as the benefit of the Group’s lower cost structure through Operational Excellence initiatives.

Electromechanical Group’s (“EMG”) net sales totaled $382.3 million for the third quarter of 2012, an increase of $41.3 million or 12.1%, compared with $341.0 million for the third quarter of 2011. The net sales increase was due to the acquisition of Dunkermotoren, partially offset by a 2% unfavorable effect of foreign currency translation.

EMG’s operating income was $77.3 million for the third quarter of 2012, an increase of $8.9 million or 13.0%, compared with $68.4 million for the third quarter of 2011. EMG’s operating margins were 20.2% of net sales for the third quarter of 2012, compared with 20.0% of net sales for the third quarter of 2011. EMG’s increase in operating income and operating margins was primarily due to the Group’s lower cost structure through Operational Excellence initiatives.

 

17


Table of Contents

Results of Operations (continued)

 

Results of operations for the first nine months of 2012 compared with the first nine months of 2011

Net sales for the first nine months of 2012 were $2,492.4 million, an increase of $265.2 million or 11.9%, compared with net sales of $2,227.2 million for the first nine months of 2011. The increase in net sales was attributable to higher order rates, as well as the impact of the acquisitions of Dunkermotoren in May 2012, O’Brien in January 2012, TMC in December 2011, EM Test and Reichert Technologies in October 2011, Coining Holding Company (“Coining”) in May 2011 and Avicenna Technology, Inc. (“Avicenna”) in April 2011. The net sales increase for the first nine months of 2012 was driven by internal sales growth of approximately 3%, which excludes a 2% unfavorable effect of foreign currency translation. The acquisitions mentioned above contributed the remainder of the net sales increase.

Total international sales for the first nine months of 2012 were $1,266.6 million or 50.8% of net sales, an increase of $146.5 million or 13.1%, compared with international sales of $1,120.1 million or 50.3% of net sales for the first nine months of 2011. The $146.5 million increase in international sales resulted from the acquisitions mentioned above, continued expansion into Asia, and includes the effect of foreign currency translation. Both reportable segments of the Company maintain a strong international sales presence in Europe and Asia despite weakness in the global economy.

New orders for the first nine months of 2012 were $2,579.4 million, an increase of $255.4 million or 11.0%, compared with $2,324.0 million for the first nine months of 2011. The increase in orders was primarily attributable to 2012 and 2011 acquisitions, excluding a 1% unfavorable effect of foreign currency translation. As a result, the Company’s backlog of unfilled orders at September 30, 2012 was $998.4 million, an increase of $87.0 million or 9.5%, compared with $911.4 million at December 31, 2011.

Segment operating income for the first nine months of 2012 was $589.2 million, an increase of $84.9 million or 16.8%, compared with segment operating income of $504.3 million for the first nine months of 2011. Segment operating income, as a percentage of net sales, increased to 23.6% for the first nine months of 2012, compared with 22.6% for the first nine months of 2011. The increase in segment operating income and segment operating margins resulted primarily from the leveraged impact of the Company’s internal sales growth increase noted above, as well as the benefits of the Company’s lower cost structure through Operational Excellence initiatives.

SG&A expenses for the first nine months of 2012 were $286.7 million, an increase of $29.5 million or 11.5%, compared with $257.2 million for the first nine months of 2011. As a percentage of net sales, SG&A expenses were 11.5% for both the first nine months of 2012 and 2011. Selling expense increased $31.9 million or 14.4% for the first nine months of 2012 primarily driven by the increase in net sales noted above. Selling expenses, as a percentage of net sales, increased to 10.2% for the first nine months of 2012, compared with 10.0% for the first nine months of 2011. Base business selling expense increased approximately 3% for the first nine months of 2012, which was in line with internal sales growth.

Corporate administrative expenses for the first nine months of 2012 were $33.1 million, a decrease of $2.4 million or 6.8%, compared with $35.5 million for the first nine months of 2011. The decrease in corporate administrative expenses was primarily the result of equity-based compensation expense associated with the accelerated vesting of an April 2009 restricted stock grant in the second quarter of 2011. As a percentage of net sales, corporate administrative expenses were 1.3% for the first nine months of 2012, compared with 1.6% for the first nine months of 2011.

Consolidated operating income was $555.9 million or 22.3% of net sales for the first nine months of 2012, an increase of $87.3 million or 18.6%, compared with $468.6 million or 21.0% of net sales for the first nine months of 2011.

Interest expense was $56.6 million for the first nine months of 2012, an increase of $4.9 million or 9.5%, compared with $51.7 million for the first nine months of 2011. The increase was primarily due to higher borrowings under revolving credit facilities for the acquisitions previously mentioned, as well as the impact of the issuance of a 55 million Swiss franc senior note in the fourth quarter of 2011.

 

18


Table of Contents

Results of Operations (continued)

 

The effective tax rate for both the first nine months of 2012 and 2011 was 31.0%. The effective tax rate for 2012 and 2011 includes the impact of international statutory tax rate reductions and the ongoing benefits obtained from international tax planning initiatives.

Net income for the first nine months of 2012 was $339.2 million, an increase of $56.6 million or 20.0%, compared with $282.6 million for the first nine months of 2011. Diluted earnings per share for the first nine months of 2012 were $1.39, an increase of $0.23 or 19.8%, compared with $1.16 per diluted share for the first nine months of 2011. Diluted earnings per share amounts were adjusted to reflect a three-for-two stock split paid to stockholders on June 29, 2012. See Note 2 to the Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Segment Results

EIG’s net sales totaled $1,378.0 million for the first nine months of 2012, an increase of $172.3 million or 14.3%, compared with $1,205.7 million for the first nine months of 2011. The net sales increase was due to internal growth of approximately 4%, excluding an unfavorable 2% effect of foreign currency translation, primarily driven by increases in EIG’s oil and gas, aerospace and power businesses. The acquisitions of O’Brien, TMC, EM Test and Reichert Technologies accounted for the remainder of the net sales increase.

EIG’s operating income was $362.3 million for the first nine months of 2012, an increase of $58.4 million or 19.2%, compared with $303.9 million for the first nine months of 2011. EIG’s operating margins were 26.3% of net sales for the first nine months of 2012, compared with 25.2% of net sales for the first nine months of 2011. The increase in segment operating income and operating margins was driven by the leveraged impact of the Group’s increase in internal sales growth noted above, as well as the benefit of the Group’s lower cost structure through Operational Excellence initiatives.

EMG’s net sales totaled $1,114.4 million for the first nine months of 2012, an increase of $93.0 million or 9.1%, compared with $1,021.4 million for the first nine months of 2011. The net sales increase was due to internal growth of approximately 1%, excluding an unfavorable 2% effect of foreign currency translation, driven by increases in EMG’s differentiated businesses. The acquisitions of Dunkermotoren, Coining and Avicenna accounted for the remainder of the net sales increase.

EMG’s operating income was $227.0 million for the first nine months of 2012, an increase of $26.6 million or 13.3%, compared with $200.4 million for the first nine months of 2011. EMG’s operating margins were 20.4% of net sales for the first nine months of 2012, compared with 19.6% of net sales for the first nine months of 2011. EMG’s increase in operating income and operating margins was primarily due to the leveraged impact of the Group’s increase in internal sales growth noted above, as well as the benefit of the Group’s lower cost structure through Operational Excellence initiatives.

 

19


Table of Contents

Financial Condition

Liquidity and Capital Resources

Cash provided by operating activities totaled $419.2 million for the first nine months of 2012, an increase of $63.4 million or 17.8%, compared with $355.8 million for the first nine months of 2011. The increase in cash provided by operating activities was primarily due to the $56.6 million increase in net income. Free cash flow (cash flow provided by operating activities less capital expenditures) was $385.9 million for the first nine months of 2012, compared with $323.4 million for the first nine months of 2011. EBITDA (earnings before interest, income taxes, depreciation and amortization) was $625.7 million for the first nine months of 2012, compared with $523.4 million for the first nine months of 2011. Free cash flow and EBITDA are presented because the Company is aware that they are measures used by third parties in evaluating the Company.

Cash used for investing activities totaled $530.4 million for the first nine months of 2012, compared with $217.1 million for the first nine months of 2011. For the first nine months of 2012, the Company paid $497.8 million for two business acquisitions, net of cash received, compared with $183.0 million paid for two business acquisitions, net of cash received, for the first nine months of 2011. Additions to property, plant and equipment totaled $33.3 million for the first nine months of 2012, compared with $32.4 million for the first nine months of 2011.

Cash provided by financing activities totaled $101.4 million for the first nine months of 2012, compared with $78.2 million of cash used for financing activities for the first nine months of 2011. The change in financing cash flow was primarily the result of the net total borrowings increase of $100.8 million for the first nine months of 2012, compared with a net total borrowings decrease of $57.3 million for the first nine months of 2011. For the first nine months of 2012, the Company repurchased 0.1 million shares of the Company’s common stock for $3.9 million, compared with $16.4 million used for repurchases of 0.6 million shares (as adjusted to reflect a three-for-two stock split paid to stockholders on June 29, 2012. See Note 2 to the Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.) of the Company’s common stock for the first nine months of 2011. At September 30, 2012, $101.6 million was available under the Board authorization for future share repurchases.

In September 2011, AMETEK completed a new five-year revolving credit facility with a total borrowing capacity of $700 million, which excludes an accordion feature that permits the Company to request up to an additional $200 million in revolving credit commitments at any time during the life of the revolving credit agreement under certain conditions. Interest rates on outstanding loans under either the current or replaced revolving credit facility are at the applicable London Interbank Offered Rate (“LIBOR”) plus a negotiated spread, or at the U.S. prime rate. The new revolving credit facility replaced a $450 million total borrowing capacity revolving credit facility, which excluded a $100 million accordion feature, that was due to expire in June 2012. The new revolving credit facility provides the Company with additional financial flexibility to support its growth plans, including its successful acquisition strategy. At September 30, 2012, the Company had available borrowing capacity of $634.8 million under its revolving credit facility, including the $200 million accordion feature.

At September 30, 2012, total debt outstanding was $1,372.2 million, compared with $1,263.9 million at December 31, 2011, with no significant maturities until 2015. The debt-to-capital ratio was 36.1% at September 30, 2012, compared with 38.1% at December 31, 2011. The net debt-to-capital ratio (total debt less cash and cash equivalents divided by the sum of net debt and stockholders’ equity) was 33.3% at September 30, 2012, compared with 34.8% at December 31, 2011. The net debt-to-capital ratio is presented because the Company is aware that this measure is used by third parties in evaluating the Company.

As a result of all of the Company’s cash flow activities for the first nine months of 2012, cash and cash equivalents at September 30, 2012 totaled $162.9 million, compared with $170.4 million at December 31, 2011. At September 30, 2012, the Company had $158.8 million in cash outside the United States. The Company utilizes this cash to operate its international operations, as well as acquire international businesses. The Company is in compliance with all covenants, including financial covenants, for all of its debt agreements. The Company believes it has sufficient cash-generating capabilities from domestic and unrestricted foreign sources, available credit facilities and access to long-term capital funds to enable it to meet its operating needs and contractual obligations in the foreseeable future.

 

20


Table of Contents

Forward-Looking Information

Information contained in this discussion, other than historical information, is considered “forward-looking statements” and is subject to various factors and uncertainties that may cause actual results to differ significantly from expectations. These factors and uncertainties include general economic conditions affecting the industries the Company serves; changes in the competitive environment or the effects of competition in the Company’s markets; risks associated with international sales and operations; the Company’s ability to consummate and successfully integrate future acquisitions; the Company’s ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; and the ability to maintain adequate liquidity and financing sources. A detailed discussion of these and other factors that may affect the Company’s future results is contained in AMETEK’s filings with the Securities and Exchange Commission, including its most recent reports on Form 10-K, 10-Q and 8-K. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements, unless required by the securities laws to do so.

Item 4. Controls and Procedures

The Company maintains a system of disclosure controls and procedures that is designed to provide reasonable assurance that information, which is required to be disclosed, is accumulated and communicated to management in a timely manner. Under the supervision and with the participation of our management, including the Company’s principal executive officer and principal financial officer, we have evaluated the effectiveness of our system of disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of September 30, 2012. Based on that evaluation, the Company’s principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures are effective at the reasonable assurance level.

Such evaluation did not identify any change in the Company’s internal control over financial reporting during the quarter ended September 30, 2012 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

21


Table of Contents

PART II. OTHER INFORMATION

Item 6. Exhibits

 

Exhibit
Number
  

Description

31.1    Certification of Chief Executive Officer, Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2    Certification of Chief Financial Officer, Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1    Certification of Chief Executive Officer, Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2    Certification of Chief Financial Officer, Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS    XBRL Instance Document.
101.SCH    XBRL Taxonomy Extension Schema Document.
101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB    XBRL Taxonomy Extension Label Linkbase Document.
101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF    XBRL Taxonomy Extension Definition Linkbase Document.

 

22


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

AMETEK, Inc.

(Registrant)

By:

  /s/ William J. Burke
  William J. Burke
  Senior Vice President - Comptroller & Treasurer
  (Principal Accounting Officer)

November 1, 2012

 

23